TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

ABON PHARMS LLC

DermatologyOncology
Generics

ABON PHARMS LLC is a generic drug manufacturer focused on Dermatology, Oncology.

2017
Since
5
Drugs
-
Trials
135
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

GABAPENTIN 2026-02-24
Labeling
GABAPENTIN 2026-02-18
Labeling
GABAPENTIN 2026-02-17
Labeling
GABAPENTIN 2026-02-17
Labeling
GABAPENTIN 2026-02-12
Labeling
VENLAFAXINE HYDROCHLORIDE 2026-01-30
Labeling
GABAPENTIN 2026-01-29
Labeling
GABAPENTIN 2026-01-29
Labeling
GABAPENTIN 2026-01-14
Labeling
GABAPENTIN 2026-01-14
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Dermatology 50%
1 drugs
Oncology 50%
1 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

Pfizer big-pharma
Oncology, Dermatology
Baxter specialty
Oncology, Dermatology
Eli Lilly big-pharma
Oncology, Dermatology
Bayer big-pharma
Oncology, Dermatology
COSETTE other
Dermatology, Oncology